Marpai (Marpai) 5-Year EBITDA Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Marpai 5-Year EBITDA Growth Rate?

Marpai's EBITDA per Share for the three months ended in Dec. 2023 was $-0.46.

During the past 3 years, the average EBITDA Per Share Growth Rate was -65.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Marpai was -65.90% per year. The lowest was -65.90% per year. And the median was -65.90% per year.

Competitive Comparison of Marpai's 5-Year EBITDA Growth Rate

For the Healthcare Plans subindustry, Marpai's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marpai's 5-Year EBITDA Growth Rate Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Marpai's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Marpai's 5-Year EBITDA Growth Rate falls into.

Marpai 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Marpai (NAS:MRAI) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Marpai 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Marpai's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Marpai (Marpai) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Marpai Inc (NAS:MRAI) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

PFHO UNH ELV CI CVS HUM CNC MOH SZSE:000503 ALHC BSP:ODPV3 OSCR CLOV BSP:QUAL3 BHG ROCO:6665 MIL:HI TSXV:NXG

Traded in Other Exchanges

N/A

Address

5701 East Hillsborough Avenue, Suite 1417, Tampa, FL, USA, 33610-5428

Website

https://www.marpaihealth.com

Marpai Inc operates as a health plan company. It uses A.I. to predict and help prevent costly events for its members, and in turn, lower its clients' health care costs. It offers a health plan services system that addresses the problems of healthcare past and enables companies to provide healthcare to employees. The company generates the majority of its revenue from the United States.

Executives

Yaron Eitan	director	65 CHALLENGER ROAD, RIDGEFIELD PARK NJ 07660
Damien Lamendola	director, 10 percent owner	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Edmundo Gonzalez	director, officer: CEO, Secretary and Director	C/O SELWAY CAPITAL ACQUISITION CORP., 74 GRAND AVENUE, 2ND FLOOR, ENGLEWOOD NJ 07631
Sagiv Shiv	director
Vincent Kane	director	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33131
Ronnie Brown	officer: Chief Operating Officer	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Mohsen Moazami	director	C/O ASTREA ACQUISITION CORP., 55 OCEAN LANE DRIVE, APT. 3021, KEY BISCAYNE FL 33149
Lutz Finger	officer: See Remarks	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610
Yoram Bibring	officer: Chief Financial Officer	C/O SELWAY ACQUISITION CORPORATION, 66 FORD ROAD, SUITE 230, DENVILLE NJ 07834
Jane Cavalier	director	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Diclaudio Colleen	director	456 SEATON STREET, LOS ANGELES CA 90013
Art Hoath	officer: Chief Revenue Officer	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Gonen Antebi	director	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Eli David	other: See footnote (1)	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33131